Jiake Tang
Impact in
- Infectious Diseases top 10%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- SARS-CoV-2 detection and testing
Papers in
-
- Liver Disease Diagnosis and Treatment 6
-
- Intensive Care Unit Cognitive Disorders 2
- Co-authors
- Mingwei Wang (19 shared papers)Chunyi Wang (15 shared papers)Mengyun Zhou (12 shared papers)Xingwei Zhang (14 shared papers)Zhanhui Feng (10 shared papers)Yongran Cheng (14 shared papers)Chen Chen (10 shared papers)Qi Wu (5 shared papers)
- Journals
- Journal of Infection (5 papers)European Journal of Ophthalmology (2 papers)Reviews in Cardiovascular Medicine (2 papers)Frontiers in Endocrinology (2 papers)BMC Cardiovascular Disorders (1 paper)
- Partner nations
- ChinaJapanUnited States
In The Last Decade
Jiake Tang
18 papers receiving 428 citations
Jiake Tang's Hit Papers
Peers
Comparison fields: 5 of 87
- Infectious Diseases 176
- Applied Microbiology and Biotechnology 8
- Neurology 47
- Epidemiology 78
- Health 18
Countries citing papers authored by Jiake Tang
This map shows the geographic impact of Jiake Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiake Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiake Tang more than expected).
Fields of papers citing papers by Jiake Tang
This network shows the impact of papers produced by Jiake Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiake Tang. The network helps show where Jiake Tang may publish in the future.
Co-authors
The 25 scholars most cited alongside Jiake Tang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Efficacy and safety of three new oral antiviral treatment (molnupiravir, fluvoxamine and Paxlovid) for COVID-19：a meta-analysis Hit paper breakdown → | 2022 | 277 |
| 2 | 2022 | 33 | |
| 3 | 2022 | 21 | |
| 4 | 2022 | 21 | |
| 5 | 2022 | 15 | |
| 6 | 2024 | 11 | |
| 7 | 2025 | 10 | |
| 8 | 2022 | 10 | |
| 9 | 2022 | 9 | |
| 10 | 2022 | 6 | |
| 11 | 2025 | 4 | |
| 12 | 2023 | 4 | |
| 13 | 2022 | 4 | |
| 14 | 2022 | 2 | |
| 15 | 2024 | 2 | |
| 16 | 2022 | 2 | |
| 17 | 2024 | 1 | |
| 18 | 2022 | 1 | |
| 19 | 2025 | 0 | |
| 20 | 2026 | 0 |
About Jiake Tang
Jiake Tang is a scholar working on Epidemiology, Critical Care and Intensive Care Medicine, Neurology, Health and Clinical Psychology, having authored 24 papers that have together received 433 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (6 papers), Long-Term Effects of COVID-19 (3 papers), Vaccine Coverage and Hesitancy (2 papers), Intensive Care Unit Cognitive Disorders (2 papers), COVID-19 and Mental Health (2 papers), Retinal Imaging and Analysis (1 paper), Sodium Intake and Health (1 paper) and Antibiotic Use and Resistance (1 paper). The work is most often cited by research in Infectious Diseases (176 citations), Applied Microbiology and Biotechnology (8 citations), Neurology (47 citations), Epidemiology (78 citations) and Health (18 citations). Jiake Tang has collaborated with scholars based in China, Japan and United States. Frequent co-authors include Mingwei Wang, Chunyi Wang, Mengyun Zhou, Xingwei Zhang, Zhanhui Feng, Yongran Cheng, Chen Chen, Qi Wu, Wen Wen and Xiang Zhou. Their work appears in journals such as Journal of Infection, European Journal of Ophthalmology, Reviews in Cardiovascular Medicine, Frontiers in Endocrinology and BMC Cardiovascular Disorders.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.